Raymond James Trust’s Eastman Chemical EMN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $8.78M | Buy |
78,432
+439
| +0.6% | +$43.9K | 0.19% | 108 |
|
|
2024
Q2 | $7.64M | Buy |
77,993
+4,859
| +7% | +$482K | 0.18% | 114 |
|
|
2024
Q1 | $7.33M | Sell |
73,134
-1,368
| -2% | -$120K | 0.18% | 117 |
|
|
2023
Q4 | $6.69M | Buy |
74,502
+1,122
| +2% | +$89.4K | 0.18% | 126 |
|
|
2023
Q3 | $5.63M | Buy |
73,380
+2,814
| +4% | +$233K | 0.17% | 131 |
|
|
2023
Q2 | $5.91M | Sell |
70,566
-1,925
| -3% | -$157K | 0.17% | 129 |
|
|
2023
Q1 | $6.11M | Buy |
72,491
+6,160
| +9% | +$529K | 0.19% | 115 |
|
|
2022
Q4 | $5.4M | Buy |
66,331
+797
| +1% | +$64.2K | 0.18% | 120 |
|
|
2022
Q3 | $4.66M | Sell |
65,534
-3,506
| -5% | -$315K | 0.17% | 120 |
|
|
2022
Q2 | $6.2M | Sell |
69,040
-5,099
| -7% | -$528K | 0.22% | 101 |
|
|
2022
Q1 | $8.31M | Sell |
74,139
-2,823
| -4% | -$331K | 0.26% | 93 |
|
|
2021
Q4 | $9.3M | Buy |
76,962
+4,432
| +6% | +$493K | 0.28% | 83 |
|
|
2021
Q3 | $7.31M | Buy |
72,530
+3,585
| +5% | +$396K | 0.24% | 96 |
|
|
2021
Q2 | $8.05M | Buy |
68,945
+3,630
| +6% | +$436K | 0.27% | 88 |
|
|
2021
Q1 | $7.19M | Buy |
65,315
+14,514
| +29% | +$1.58M | 0.25% | 93 |
|
|
2020
Q4 | $5.09M | Buy |
50,801
+1,746
| +4% | +$162K | 0.19% | 111 |
|
|
2020
Q3 | $3.83M | Buy |
49,055
+576
| +1% | +$43.4K | 0.17% | 123 |
|
|
2020
Q2 | $3.38M | Sell |
48,479
-287
| -0.6% | -$18.1K | 0.16% | 129 |
|
|
2020
Q1 | $2.27M | Buy |
48,766
+12,483
| +34% | +$802K | 0.13% | 147 |
|
|
2019
Q4 | $2.88M | Buy |
36,283
+2,152
| +6% | +$165K | 0.14% | 144 |
|
|
2019
Q3 | $2.52M | Sell |
34,131
-735
| -2% | -$52.7K | 0.13% | 160 |
|
|
2019
Q2 | $2.71M | Buy |
34,866
+491
| +1% | +$37.3K | 0.15% | 140 |
|
|
2019
Q1 | $2.61M | Sell |
34,375
-2,462
| -7% | -$196K | 0.15% | 144 |
|
|
2018
Q4 | $2.69M | Buy |
36,837
+43
| +0.1% | +$3.43K | 0.17% | 127 |
|
|
2018
Q3 | $3.52M | Buy |
36,794
+242
| +0.7% | +$24K | 0.2% | 112 |
|
|
2018
Q2 | $3.65M | Sell |
36,552
-6,215
| -15% | -$656K | 0.22% | 106 |
|
|
2018
Q1 | $4.51M | Buy |
42,767
+8,349
| +24% | +$844K | 0.31% | 85 |
|
|
2017
Q4 | $3.19M | Buy |
34,418
+350
| +1% | +$31.8K | 0.21% | 110 |
|
|
2017
Q3 | $3.08M | Buy |
34,068
+1,847
| +6% | +$157K | 0.22% | 107 |
|
|
2017
Q2 | $2.71M | Buy |
32,221
+5,246
| +19% | +$423K | 0.2% | 117 |
|
|
2017
Q1 | $2.18M | Buy |
26,975
+3,249
| +14% | +$256K | 0.17% | 133 |
|
|
2016
Q4 | $1.78M | Buy |
23,726
+7,364
| +45% | +$532K | 0.14% | 157 |
|
|
2016
Q3 | $1.11M | Buy |
16,362
+2,742
| +20% | +$184K | 0.1% | 204 |
|
|
2016
Q2 | $925K | Buy |
13,620
+729
| +6% | +$53.6K | 0.08% | 225 |
|
|
2016
Q1 | $931K | Buy |
12,891
+6,351
| +97% | +$416K | 0.09% | 225 |
|
|
2015
Q4 | $442K | Buy |
6,540
+675
| +12% | +$47.2K | 0.04% | 357 |
|
|
2015
Q3 | $379K | Buy |
5,865
+255
| +5% | +$18.8K | 0.04% | 362 |
|
|
2015
Q2 | $459K | Buy |
5,610
+372
| +7% | +$28.7K | 0.05% | 336 |
|
|
2015
Q1 | $362K | Buy |
5,238
+2,073
| +65% | +$150K | 0.04% | 400 |
|
|
2014
Q4 | $240K | Sell |
3,165
-252
| -7% | -$19.9K | 0.03% | 516 |
|
|
2014
Q3 | $277K | Buy |
3,417
+982
| +40% | +$82K | 0.03% | 463 |
|
|
2014
Q2 | $212K | Sell |
2,435
-331
| -12% | -$28.8K | 0.02% | 537 |
|
|
2014
Q1 | $238K | Sell |
2,766
-1,720
| -38% | -$141K | 0.03% | 470 |
|
|
2013
Q4 | $362K | Sell |
4,486
-179
| -4% | -$13.9K | 0.05% | 339 |
|
|
2013
Q3 | $364K | Buy |
4,665
+535
| +13% | +$41.2K | 0.06% | 310 |
|
|
2013
Q2 | $290K | Buy |
+4,130
| New | +$288K | 0.05% | 336 |
|
Other funds holding EMN
Raymond James Trust's EMN Position: Q3 2024 in Review
Raymond James Trust increased its Eastman Chemical (EMN) stake by 0.56% in Q3 2024, buying an estimated $43.9K and bringing the position to 78,432 shares worth $8.78M. The position accounts for 0.19% of the portfolio, ranked #108.
Raymond James Trust first reported a position in EMN in Q2 2013 and has held it in 46 quarters since. The position peaked at $9.3M in Q4 2021. 782 funds tracked by Wall St. Rank hold EMN as of Q3 2024.
- Raymond James Trust held 78,432 shares of Eastman Chemical worth $8.78M as of Q3 2024.
- Raymond James Trust bought 439 Eastman Chemical shares in Q3 2024, an estimated $43.9K.
- Eastman Chemical made up 0.19% of Raymond James Trust's portfolio in Q3 2024, its #108 holding.
- Raymond James Trust first reported a position in Eastman Chemical in Q2 2013 and has held it in 46 quarters since.
- Raymond James Trust's Eastman Chemical position peaked at $9.3M in Q4 2021.
- 782 funds tracked by Wall St. Rank held Eastman Chemical as of Q3 2024.
Based on Raymond James Trust's 13F filing for Q3 2024, filed 12 Nov 2024.